Sinopharm Group and Others Establish Pharmaceutical Technology Company in Hainan

MetaMuskRat · 2026-03-17T06:14:47+00:00

People Finance News, March 16 — According to the Qichacha APP, Shiyao Cell Valley (Hainan) Pharmaceutical Technology Co., Ltd. was recently established with Xiao Benjing as the legal representative and registered capital of 20 million yuan. The business scope includes medical services; pharmaceutical production; life beauty services; medical research and experimental development; human stem cell technology development and application, among others. Equity penetration analysis by Qichacha shows that the company is jointly held by Shiyao Holding Group Co., Ltd., Shenzhen Cell Valley Biomedicine Co., Ltd., and others.

MetaMuskRat

2026-03-17 06:14:47

People’s Financial News, March 16 — According to Qichacha, Shiyao Cell Valley (Hainan) Pharmaceutical Technology Co., Ltd. was recently established. The legal representative is Xiao Benjing, with a registered capital of 20 million yuan. Its business scope includes medical services; pharmaceutical manufacturing; personal beauty services; medical research and experimental development; human stem cell technology development and application, among others. Qichacha’s equity penetration shows that the company is jointly held by Shiyao Holding Group Co., Ltd., Shenzhen Cell Valley Biopharmaceutical Co., Ltd., and others.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.